ImmuPharma (LON:IMM) Shares Up 83.3% – Still a Buy?

ImmuPharma plc (LON:IMM) shares shot up 83.3% during trading on Thursday . The stock traded as high as GBX 2.49 ($0.03) and last traded at GBX 2.20 ($0.03). 33,956,879 shares were traded during mid-day trading, an increase of 417% from the average session volume of 6,568,868 shares. The stock had previously closed at GBX 1.20 ($0.01).

ImmuPharma Stock Performance

The stock’s 50 day simple moving average is GBX 1.36 and its 200 day simple moving average is GBX 1.63. The firm has a market cap of £8.33 million, a P/E ratio of -200.00 and a beta of 1.53.

ImmuPharma Company Profile

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.